EXHIBIT 21.1
SUBSIDIARIES OF GYRE THERAPEUTICS, INC.
Note: Gyre Therapeutics, Inc. or one of its Subsidiaries has 100% ownership of the Subsidiaries listed below, except for Beijing Continent Pharmaceuticals Co., Ltd. (65.2%) and Beijing Continent Biomedical Technology Co., Ltd (65.2%).
Subsidiaries |
Jurisdiction |
Further Challenger International Limited |
British Virgin Islands |
Nepenthe Holdings Limited |
Hong Kong |
Ratel Holdings Limited |
British Virgin Islands |
Aaring Limited |
Hong Kong |
Rosefinch Holdings Limited |
British Virgin Islands |
Continent Pharmaceuticals Inc. |
Cayman Islands |
BJContinent Pharmaceuticals Limited |
Hong Kong |
Beijing Continent Pharmaceuticals Co., Ltd. |
People’s Republic of China |
Beijing Continent Biomedical Technology Co., Ltd. |
People’s Republic of China |